Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Babies with Chromosomal Disorders owing to Increasing Number of Late Pregnancies
4.2.2 Increasing Demand for Early and Non-invasive Fetal Diagnosis
4.2.3 Favorable Reimbursement Policies
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.3.2 Stringent Regulations and Ethical Concerns
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Component
5.1.1 Instruments
5.1.2 Kits and Reagents
5.1.3 Services
5.2 Application
5.2.1 Down syndrome (trisomy 21)
5.2.2 Edwards syndrome (trisomy 18)
5.2.3 Patau syndrome (trisomy 13)
5.2.4 Turner syndrome
5.2.5 Others
5.3 End User
5.3.1 Hospitals
5.3.2 Diagnostic Labs
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BGI
6.1.2 CENTOGENE AG
6.1.3 Eurofins Scientific
6.1.4 F. Hoffmann-La Roche Ltd (Roche Sequencing)
6.1.5 Invitae Corporation
6.1.6 Illumina, Inc.
6.1.7 Natera, Inc.
6.1.8 Progenity, Inc.
6.1.9 PerkinElmer Inc.
6.1.10 Quest Diagnostics


7 MARKET OPPORTUNITIES AND FUTURE TRENDS